NEW YORK, NY — As the calendar turns to October, the world is traditionally bathed in a sea of pink ribbons, a symbol synonymous with breast cancer awareness and the triumph of early detection. However, for those living with metastatic breast cancer (MBC), also known as Stage 4, the “pink” narrative often feels incomplete, if not entirely exclusionary. On October 13, 2026—National Metastatic Breast Cancer Awareness Day—the conversation is set to shift from early detection to the urgent reality of the disease’s terminal stage.
Through the global campaign #LightUpMBC, organized by METAvivor Research and Support, more than 325 landmarks across all 50 U.S. states and 20 countries will illuminate in a distinct tri-color palette of teal, green, and pink. This massive coordinated effort aims to bring visibility to a population often overshadowed during Breast Cancer Awareness Month, honoring those lost to the disease and raising critical funds for research that seeks to turn a terminal diagnosis into a manageable, chronic condition.
Main Facts: A Tri-Color Movement for Research
The #LightUpMBC campaign is not merely a symbolic gesture; it is a call to action. While standard breast cancer awareness focuses heavily on screening and "finishing treatment," MBC patients face a different reality: they are never finished with treatment. MBC occurs when cancer spreads beyond the breast to vital organs such as the bones, liver, lungs, or brain. Currently, there is no cure.
The 2026 campaign represents the largest iteration of the movement to date. Landmarks ranging from the One World Trade Center in New York City to the Mactan-Cebu Airport in the Philippines will glow in teal (representing the spirit and the community), green (representing the triumph of spring over winter and the renewal of hope), and pink (acknowledging the breast cancer origin).
Central to the day’s events is #LightUpMBC Live, a free global broadcast airing at 8 p.m. ET / 5 p.m. PT. Hosted by Tami Eagle Bowling, an 11-year MBC survivor and advocate, and Broadway star Kara Lindsay, the program will feature a blend of scientific education, patient testimonials, and high-profile musical performances. Crucially, 100% of the net proceeds from the campaign and the livestream are funneled directly into METAvivor’s research grants, which exclusively fund Stage 4 metastatic research.
Chronology: From a Single Bridge to a Global Phenomenon
The origins of #LightUpMBC are rooted in a personal story of friendship and a modest wish. In 2017, Jessica Moore, a young woman diagnosed with metastatic breast cancer at the age of 32, expressed a wish to see a local landmark lit up in MBC awareness colors to help people understand that her disease was different from the "curable" versions often discussed in the media.
Following Jessica’s passing at age 36, her best friend, Laura Inahara, took up the mantle. What began as a single illumination of the Memorial Bridge in Portsmouth, New Hampshire, has evolved over the last nine years into a sophisticated international operation.
- 2017: The first landmark, Memorial Bridge (NH), illuminates for MBC.
- 2018–2020: The campaign gains traction across the United States, moving from a handful of bridges to dozens of city halls and skyscrapers.
- 2021: Despite the challenges of the pandemic, the campaign transitions into a digital powerhouse with the introduction of #LightUpMBC Live, reaching a global audience through streaming.
- 2023–2025: The movement goes truly international, securing participation from landmarks in Europe, Asia, and South America. The campaign crosses the $2 million mark in total funds raised.
- 2026: The current campaign hits a record 325+ landmarks, cementing October 13 as a cornerstone of the global health calendar.
Supporting Data: The Stark Reality of Stage 4
The necessity of #LightUpMBC is underscored by sobering statistics provided by the National Cancer Institute’s SEER (Surveillance, Epidemiology, and End Results) program. In 2026, it is estimated that 42,670 people in the United States will die from breast cancer. This averages out to approximately 117 deaths every single day. Nearly all of these deaths are the result of metastatic disease.
Despite these figures, historical funding for breast cancer research has been disproportionately allocated toward prevention and early-stage treatment. Estimates suggest that only 7% to 10% of total breast cancer research funding is directed toward metastatic disease. METAvivor was founded to fill this gap, ensuring that the people currently living with the disease—and those who will inevitably be diagnosed in the future—have access to life-extending therapies.
The biological complexity of MBC makes it a difficult target for researchers. Because the cancer can appear in different organs and often mutates to become resistant to specific therapies, patients are frequently forced to cycle through various "lines" of treatment. When one drug stops working, they move to the next, hoping that science stays one step ahead of the tumor’s growth.
Official Responses: Leadership on the Front Lines
For the leadership at METAvivor, the campaign is deeply personal. Dr. Kelly Shanahan, the Board President of METAvivor, is herself a physician living with the disease. Her perspective bridges the gap between clinical necessity and patient advocacy.
“When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later,” Dr. Shanahan remarked. “My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community.”
Laura Inahara, the founder of the #LightUpMBC campaign, views the 2026 scale as a fulfillment of Jessica Moore’s legacy. “Jessica hoped to illuminate one local landmark,” Inahara said. “Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research.”
The 2026 livestream also brings together the arts and sciences. The program will feature insights from leading oncologists alongside performances by two-time Tony Award winner Victoria Clark and Tony Award nominee Dorian Harewood. This interdisciplinary approach is designed to engage a general public that may be "fatigued" by traditional charity messaging, using the power of music and storytelling to drive home the urgency of the cause.
Implications: Changing the Narrative of Survival
The implications of the #LightUpMBC campaign extend far beyond a single night of colored lights. By focusing exclusively on Stage 4, METAvivor is challenging the "survivorship" culture that often leaves the terminally ill feeling like failures of the medical system.
1. Transforming the "Terminal" Label:
The ultimate goal of the research funded by this campaign is to transform MBC into a chronic, manageable condition, similar to HIV or Type 1 diabetes. By funding projects that specifically target the mechanisms of metastasis and drug resistance, METAvivor is pushing the medical community toward a future where "Stage 4" does not automatically mean a death sentence.
2. Global Advocacy and Policy:
The visibility of 325 landmarks serves as a powerful lobbying tool. When iconic structures like the Willis Tower in Chicago or Philadelphia City Hall change their colors, it forces a public conversation. This awareness can influence policy decisions regarding drug pricing, healthcare access, and federal research appropriations.
3. Community and Mental Health:
For patients, the #LightUpMBC campaign provides a sense of belonging. The "Pink Ribbon" month can be a lonely time for MBC patients who know they will never be "cancer-free." Seeing their specific colors—teal and green—on the world’s most famous buildings validates their experience and provides a visual reminder that they are not forgotten.
4. Financial Impact on Scientific Innovation:
With over $2.7 million raised to date, the #LightUpMBC campaign has become a vital engine for scientific innovation. METAvivor’s unique peer-review process, which includes both scientists and patient advocates, ensures that the research being funded is not only scientifically sound but also holds the most promise for improving the actual quality of life for patients.
As the lights go up on October 13, the message is clear: Awareness is the first step, but action through research is the only way to change the statistics. The public is encouraged to participate by photographing their local illuminated landmarks and sharing them via social media using the hashtags #LightUpMBC and #METAvivor, ensuring that the glow from these 325 landmarks reaches every corner of the globe.
For more information on participating landmarks, to view the #LightUpMBC Live stream, or to make a donation, please visit www.lightupmbc.org.
About the Author
